[Demonstration of 3'5'-cyclic AMP phosphodiesterase activity in the human placenta at term].
D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D012964:Sodium / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D007093:Imidazoles; D014316:Tritium; D002110:Caffeine; D007986:Luteinizing Hormone; D012964:Sodium; D013806:Theophylline; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D010727:Phosphoric Diester Hydrolases; D005459:Fluorides; D009638:Norepinephrine; D004837:Epinephrine
Mise en évidence d'une activité 3'5'-AMP cyclique phosphodiestérase dans le placenta humain à terme.